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ABSTRACT  We studied the intracellular transport of secretory and membrane proteins in the 
human hepatoma cell line HepG-2 infected with vesicular stomatitis virus. Cells were pulse- 
labeled in the presence of [3SS]methionine  and chased in the presence of the lysosomotropic 
agent primaquine. At a concentration of 0.3 mM primaquine effectively inhibited the secretion 
of albumin and, to a lesser extent, that of orosomucoid and transferrin. The drug also prevented 
the  budding  of  virus  particles  at  the  cell  surface.  The  intracellular  transport  to  the  Golgi 
complex  of  the  membrane  protein  VSV-G  was  not  affected  by  primaquine  as  it  acquires 
resistance to endo-/~-N-acetylglucosaminidase H at the same rate as in control cells.  Addition 
of primaquine at various times after the initiation of the chase period indicates that the effect 
of primaquine  occurs just before secretion.  In confirmation  of the biochemical  data,  immu- 
nocytochemical localization of albumin in cells treated with NH4CI demonstrated that albumin 
accumulated  in vesicles  at the trans  side of the Golgi complex.  The effect of primaquine on 
secretion was also compared with its effect on receptor recycling.  The dose-response char- 
acteristics of the effect of primaquine on receptor recycling are identical to those of the effects 
on protein secretion and virus budding. These results indicate that both processes involve the 
same  transport  mechanism,  and/or  that  they  occur  via  at  least  one  identical  intracellular 
compartment. 
Secretory  and  plasma  membrane proteins are  transported 
from the rough endoplasmic reticulum (RER) ~ via the Golgi 
complex to the cell exterior. The transport rate between the 
RER and the Golgi complex differs for individual proteins 
and  varies  between  20  and  120  min.  In  rat  and  human 
hepatoma cells infected with vesicular stomatitis virus (VSV), 
albumin and the viral membrane protein VSV-G pass through 
the  Golgi complex within  20  rain  after synthesis,  whereas 
transferrin remains in the RER for almost 2 h before acqui- 
sition of the complex sugar configuration (29). After passage 
through  the  Golgi  complex  secretory  and  membrane 
(glyco)proteins  rapidly  (within  a  few  minutes)  reach  the 
plasma membrane. 
Abbreviations used in this paper: ASGP, asialoglycoprotein;  ASOR, 
asialoorosomucoid; endo H, endo-a-N-acetylglucosaminidase;  RER, 
rough endoplasmic reticulum; VSV, vesicular stomatitis virus. 
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Another intracellular pathway in which proteins are specif- 
ically targetted along specific routes is that of receptor-medi- 
ated endocytosis of extracellular ligands.  The occurrence of 
receptor recycling has been inferred from studies of a variety 
of receptor-ligand systems in  many different cells,  i.e.,  the 
receptor-mediated systems for delivery of low density lipopro- 
rein, transferrin, lysosomal enzymes, and asialoglycoproteins 
(ASGPs) in hepatocytes. During receptor-mediated endocy- 
tosis, a ligand binds to a specific cell surface receptor, and the 
receptor-ligand  complex  is  internalized  via  a  coated  pit- 
coated vesicle  pathway. Many ligands dissociate from their 
receptor in a prelysosomal, acidic compartment and allow the 
receptors to recycle back to the cell surface (1, 27).  Neither 
the  underlying  mechanism  nor  the  route  for recycling  of 
receptors back  to  the  plasma  membrane  is  known.  From 
studies of the asialoglycoprotein receptor in a human hepa- 
531 tocyte-derived cell line, hepatoma HepG2, it is known that a 
single receptor molecule can recycle from the cell surface into 
a compartment of uncoupling receptor and ligand (CURL) 
within the cell and back to the cell surface within 8 rain (6, 
9, 22).  Acidification within (some of) the endocytotic struc- 
tures may play a role in ASGP-receptor recycling (25, 33). 
Both isolated endosomal and Golgi vesicles contain an H ÷ 
pump that results in acidification of these compartments (l 1, 
35, 36). Lysosomotropic agents such as the weak bases chlor- 
oquine, primaquine, and NI-LCI raise the pH of acidic intra- 
cellular compartments. Studies following the fate of receptors 
and labeled ligands demonstrate that these agents interrupt 
recycling of some receptors with their consequent accumula- 
tion in an endosomal compartment (3,  12, 25). These obser- 
vations suggest  that the  lysosomotropic amines inhibit  the 
pathway by which the receptors return to the plasma mem- 
brane. 
In the present study we have examined the effect of pri- 
maquine and NH4CI on the intracellular transport of  secretory 
proteins and of the transmembrane glycoprotein VSV-G in 
human  hepatoma HepG2 cells infected with  vesicular sto- 
matitis  virus.  In  primaquine-treated  cells  the  intracellular 
transport of secretory and membrane proteins is inhibited as 
compared with untreated cells. However, the degree of inhi- 
bition varies among the proteins examined. Both biochemical 
and  immunoccytochemical  findings  demonstrate  that  the 
block is localized at or just distal to the trans side of the Golgi 
complex. In addition we have compared the effect of prima- 
quine on protein secretion with its effect on the recycling of 
the ASGP-receptor. 
MATERIALS  AND  METHODS 
Cells and Viruses:  The human hepatoma cell line HepG2 (clone al6) 
was cultured  in monolayer  in Eagle's minimal  essential medium  containing 
10% decomplemented  fetal bovine serum (23). The Indiana  serotype of VSV 
was originally obtained from C. Pringle (Institute of Virology, Glasgow, U.K.). 
Maintenance of the cells and virus infection were detailed earlier (23, 29). 
Labeling of Cells:  Almost confluent HepG2 cells grown on 35-ram 
petri  dishes were pulse-labeled with  [3~S]methionine (20-30  #Ci/ml)  (800- 
1,200 Ci/mmol; The  Radiochemical  Centre, Amersham  U.K.), chased with 
unlabeled methionine, and lysed in 1% Triton X-100, 0.1  mM phenylmethyl- 
sulfonyl fluoride in phosphate-buffered saline (PBS). Primaquine (0.3 raM) was 
added after the radioactive labeling and was generally present throughout the 
entire chase period. 
Immunoprecipitation and SDS PAGE:  Aliquotsofthe  Triton X- 
100-soluble material were immunoprecipitated  with either normal rabbit IgG 
(control) or affinity purified rabbit anti-rat  ASGP-R, rabbit anti-human  oro- 
somucoid, rabbit anti-human  albumin,  rabbit anti-human  transferrin (DAK- 
OPATTS, Denmark), monoclonal anti-VSV-G (clone c-l, a-7, kindly provided 
by Dr. M. Pasternak, Massachusetts Institute of Technology). Gel electropho- 
resis was  performed  in  10%  polyacrylamide  gels in  the  presence of SDS. 
Immunoprecipitations  were performed as previously described (28). After dec_ 
trophoresis the gels were fluorographed and the fluorograms were scanned with 
a  mierodensitometer  (E-C Apparatus  Corp.,  St.  Petersburg, FL) within  the 
linear range of the film and the microdensitometer.  Endo-B-N-acetylglucosa- 
minidase H (undo H) digestion of immunoprecipitated  proteins was performed 
as previously described (29). 
Binding of 1251-Asialoorosomucoid  (12SI-ASOR)  to Cell Sur- 
face:  The binding of ~2Sl-ASOR to HepG2 cells at 4"C has been described 
(23); specific binding is defined as the difference of binding of t2~I-ASOR in the 
absence and presence of 100-fold excess unlabeled ASOR. Binding was assayed 
in Eagle's minimal  essential medium containing  10  mM HEPES (pH 7.3) 
during a 2-h period. 
fixation  and  Immunocytochemistry:  Cells  attached  to culture 
dishes were fixed in  1% acrolein in 0.1  M sodium phosphate buffer, pH 7.4, 
for 30 rain and thereafter in 0.5% glutaraldehyde in 0.1 M sodium phosphate 
buffer for 60  min at 4"C. The cells were then  rinsed twice with the buffer, 
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scraped offofthe dish, and resuspended in 10% gelatin (37"C). After 2 min the 
suspension was centrifuged and the pellet was flattened at 0*C to provide a very 
thin  layer of solidified gelatin containing the fixed cells. Cells were stored in 
8% paraformaldehyde and  1 M sucrose at 4"C. 
Cryosectioning, immunolabeling, staining, and embedding were carried out 
as detailed  previously (9). Double-immunogold  labeling was performed  as 
described (10) with two sizes of monodisperse colloidal gold particles, prepared 
according to Slot and Geaze (26). Affinity purified antibodies were applied at 
a concentration  of 0.05 mg/ml. Control  sections were treated  with affinity 
purified anti rat pancreatic amylase. Background labeling was negligible. 
RESULTS 
Effect of Primaquine on Secretion and 
Virus Production 
To study the effect of primaquine on intracellular transport 
of secretory and membrane proteins HepG2 cells  were in- 
fected with VSV and pulse-labeled in the presence of [355]- 
methionine. Fig.  I. shows that both viral proteins and hepa- 
toma specific secretory proteins appear in the tissue culture 
medium by 40 min of chase.  Except for membrane glycopro- 
tein G, viral proteins are incorporated into virus particles after 
short chases (radioactive VSV-M and VSV-N (NS) are clearly 
present). After longer chases various hepatoma products are 
secreted, albeit at different rates.  In the presence of 0.3  mM 
primaquine the secretory process is markedly inhibited.  Es- 
sentially  no  radioactive  labeled  albumin  and  VSV-G  are 
present  in  the  media  after  3  h  of chase.  In  addition,  the 
process of virus budding is substantially reduced, as seen by 
the amount of VSV-L in the media. Quantitative immuno- 
precipitation  of specific  proteins  present  in  the  cells  after 
various chase times is shown in Fig. 2. The effect of prima- 
quine on the secretion of individual proteins varies. Whereas 
albumin secretion is almost totally inhibited in the presence 
of 0.3  mM  primaquine,  the  release  of orosomucoid  and 
transferrin  is  only  delayed:  half of the  newly  synthesized 
orosomucoid is normally secreted in <60 rain, whereas in the 
presence of primaquine > 120 rain are required for secretion 
of 50%  of this protein.  A similar delay is observed for the 
secretion of al-antitrypsin (not shown). 
Primaquine Does Not Interfere with Protein 
Transport between the RER and the 
Golgi Complex 
We have used the enzyme undo H as an analytical tool for 
transport of VSV-G from the  RER to the Golgi complex. 
During this movement from the RER and through the Golgi 
complex, N-linked  oligosaccharides  undergo  a  number  of 
modification reactions,  including  removal of three glucose 
and  six  mannose residues,  and the subsequent addition of 
acetylglucosamine, galactose, and  sialic  acid.  The enzymes 
involved in these reactions are presumably present at specific 
sites along the transport route through the RER and the Golgi 
complex (4,  31).  The acquisition of resistance to undo H  is 
thought to take place in the middle of the Golgi stack. Fig. 3 
shows  that  in  the  presence or  absence of primaquine  the 
membrane protein  VSV-G acquires  resistance to  undo  H. 
This  indicates  that  primaquine  neither  affects the  initial 
processing of N-linked oligosaccharides nor alters the  time 
required to reach the processing sites in the Golgi complex. 
Both in the presence and absence of primaquine more than 
90% of VSV-G becomes endo H-resistant within 20 min of 
chase. FIGURE  1  Time  course  of secretion of  [~sS]- 
methionine-labeled proteins into the medium. 
HepG2 cells grown on 35-ram plates were in- 
fected with VSV, pulse labeled for 10 min, and 
then chased in the presence of 1 ml unlabeled 
chase  medium. At  the  indicated times  10-~1 
samples were taken and analyzed on  polyac- 
rylamide  gels.  The  2,5-diphenyloxazole im- 
pregnated gel was dried and exposed to x-ray 
film for 3 d. Lanes 2-8 show patterns of control 
cells. Lanes 9-15 show patterns of cells chased 
in the presence of 0.3 mM primaquine. Lanes 
1 and 16 show molecular weight standard  pro- 
teins.  The VSV proteins and albumin are indi- 
cated to the right of the figure. 
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FIGURE  2  Effect of primaquine on protein se- 
cretion. VSV-infected  cells were pulse-labeled 
and chased as described in the legend to Fig. 
1. Proteins were immunoprecipitated  from the 
lysed  ceils  and  analyzed on  polyacrylamide 
gels, the gels were fluorographed,  and the fluo- 
rograms were scanned.  The relative amounts 
of radioactive  protein are plotted as percentage 
of radioactivity initially present in the cells. O, 
control cells; e, primaquine-treated  cells. ALB, 
albumin; ORO, orosomucoid; TF, transferrin. 
Effect of Primaquine Removal on the Appearance 
of Secretory and Membrane Proteins at the 
Cell Exterior 
The transport rate of glycoproteins between the RER and 
the  Golgi complex was probed by the  susceptibility to  the 
enzyme endo H. These studies demonstrate that primaquine 
does  not  interfere  with  either  the  kinetics  or  route  of the 
(glyco)proteins in this portion of their intracellular transport. 
To dissect further the localization of primaquine action we 
determined the effect of removal of the drug on the transport 
rate of newly synthesized proteins. VSV-infected HepG2 cells 
were  pulse-labeled in  the  presence  of [3SS]methionine  and 
then chased in the presence or absence of primaquine for 2 h 
(Fig.  4).  In control cells (without primaquine) (Fig.  4,  lanes 
1-8) secretory proteins and virus particles began to appear in 
the medium within 30 min. Whereas some proteins reached 
a plateau shortly thereafter, other proteins initially appeared 
only after 60 or 90 min and did not reach a plateau even after 
2 h of chase. In the presence of primaquine very little radio- 
STROUS 
active protein became apparent in the medium after 2 h  of 
chase (Fig. 4, lane 9). However, removal of primaquine from 
the  cells was followed by a  rapid  secretion  of the  labeled 
proteins: after 5 or l0 min most proteins are easily identified 
in the medium. Quantification of  the secretory products shows 
that the kinetics of  secretion and virus budding are completely 
different in control and primaquine-treated cells (Fig.  5). In 
the control situation individual proteins exhibit different rates 
of secretion, whereas after primaquine removal all secretory 
proteins leave the cells in synchrony. The effect of  the removal 
of primaquine on protein secretion and on virus budding is 
again identical. Recovery of the cells after primaquine incu- 
bation for 2 h apparently is neither instantaneous nor com- 
plete, as it takes a  considerable time for the  proteins to be 
completely secreted. However, it is clear that incubation with 
primaquine does not interfere with the transport of  membrane 
protein (i.e.,  VSV-G) or the  secretory proteins through  the 
intraceUular site at which these proteins are retarded differ- 
ently on route to the plasma membrane. This site presumably 
lies before the Golgi complex (14). 
EX AL.  Effect  of Primaquine on Secretion  and  Receptor  Recycling  533 FIGURE  3  endo  H  digestion  of 
VSV-G.  Labeling  and  sample 
preparation were as described in 
the  legend to  Fig.  1.  The chase 
times  were  as  indicated  in  the 
figure. After immunoprecipitation 
each sample was digested for 18 
h  in the presence  or absence of 
endo H before separation on gels 
as  described  in  Materials  and 
Methods. Top, control cells; bot- 
tome primaquine-treated  cells. 
FIGURE  4  Effect  of removal of pri- 
maquine on secretion.  After VSV-in- 
fected cells were pulse-labeled  for 10 
min, the medium was replaced by 3- 
ml chase medium containing 50 #M 
unlabeled methionine and  0.3  mM 
primaquine. The  cells  were chased 
for 2 h at 37°C; then a 10-pl sample 
was taken for analysis by gel electro- 
phoresis (lane 9). Thereafter the cells 
were put on  ice  and  washed  three 
times with 5 m[ PBS (pH 7.4) at 0°C 
for 5 min each to remove primaquine 
from the cells. 3 ml prewarmed  chase 
medium  (without  primaquine)  was 
then added, and 10-pl samples were 
taken at the times indicated in  the 
figure for analysis by gel electropho- 
resis (lanes  10-18). In  control  cells 
(no primaquine  added) 10-pl samples 
were  taken  at  the  indicated  times 
after the  pulse  labeling (lanes  1-8). 
The  VSV  proteins and  albumin are 
indicated to the  right of the figure. 
~r, see legend to Fig. 5. 
Where Does Primaquine Affect the Transport of 
Secretory Proteins?. 
Thus far, the kinetic data localize the intracellular  site of 
primaquine action to a position distal  to both the RER and 
the cis-Golg~. To obtain a more precise picture of the primary 
effect  VSV-infected  HepG2  cells  were  pulse-labeled  in  the 
534  THE  JOURNAL OF  CELL BIOLOGY . VOLUME 101, 1985 
presence  of [35S]methionine  and  then  chased  for  2  h.  At 
different  times 0.3  mM of primaquine Was added.  Because 
the effect of primaquine on intracellular  transport is almost 
instantaneous (1-2 min; reference 25) this experiment allows 
a direct determination of  the time at which primaquine affects 
transport.  The results  are  presented  in  Figs.  6 and  7.  The 
addition of primaquine after l0 or 20 min of chase prevented & 
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FIGURE  5  Time course of secretion after removal of primaquine. 
The  proper exposure of the gel  used  in  Fig.  4  (lanes 10-18)  was 
scanned and the amounts of labeled protein were quantitated and 
plotted in the figure. The kinetics of secretion of albumin and VSV- 
G  were identical  in  Fig.  4; O,  albumin and VSV-G; @, VSV-L;  "~, 
protein indicated with a star in Fig. 4. A, control cells; B, cells chased 
in the presence of primaquine as described in the legend to Fig. 4. 
secretion almost totally during the remaining 100 or 110 min 
of chase. However, primaquine addition after 30 min failed 
to  alter  the  appearance  of most  secretory proteins  in  the 
medium. Quantitation of the disappearance from the cells of 
albumin, orosomucoid, and transferrin after immunoprecip- 
itation and gel electrophoresis (Fig.  7) allows the determina- 
tion of the precise time after the initiation of the chase period 
at which the drug maximally interferes with the intracellular 
transport. The time at which 50% of the pulse-labeled albu- 
min has passed the intracellular site of primaquine action is 
24  min; orosomucoid requires  70  min  and  transferrin  115 
min to arrive at this point. There is a remarkable similarity 
between these values and the times required for the secretion 
of these proteins.  As the  transport of secretory proteins  in 
hepatoma cells is dependent mainly on the time required for 
transport between the RER and the Golgi complex (29),  it is 
clear that primaquine exerts its effect after the proteins have 
left the intracellular compartment where differences in trans- 
port rate arise. 
Immunoelectron  Microscopy 
Immunocytochemistry  of VSV-infected HepG2 cells makes 
it possible to characterize morphologically the site at which 
primaquine affects the intracellular transport.  For these ex- 
periments we used NH4CI as the lysosomotropic amine, since 
primaquine inhibits protein synthesis substantially at the con- 
centration required to inhibit secretion (0.3  raM). At a con- 
centration of 10 mM NH4CI albumin synthesis is essentially 
unaffected, whereas its secretion is inhibited by 72%.  By its 
immunogold  labeling  pattern  in  ultrathin  cryosections we 
could localize the main concentration of albumin in control 
cells  in  the Golgi complex (Fig.  8A).  In ceils  grown  in  the 
presence of NH4C1 larger vacuoles occurred, often at the trans 
side of the  Golgi complex,  in  which  albumin  appeared to 
accumulate. As we pointed out in the introduction, lysosom- 
otropic agents such as primaquine and NI-GC1  not only inter- 
fere with intracellular transport of secretory and membrane 
proteins, but they also dramatically affect the receptor-medi- 
ated endocytosis. Thus, we have compared the effect of lyso- 
somotropic agents on the cellular distribution of  albumin with 
that  of the  ASGP  receptor.  From  sections  co-labeled  for 
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albumin and the ASGP-receptor it is clear that both labels are 
present in the same diluted vesicles distal to the Golgi complex 
(Fig. 8 B). Because of this localization these vesicles are prob- 
ably trans-Gol# reticulum or secretory vesicles. Both albumin 
and ASGP-receptor labeling is scarce over the Golgi complex. 
These  results  indicate  that  after 2  h  of NH,C1  treatment 
albumin accumulates in vesicles between the Golgi complex 
and the cell surface but not in the Golgi complex. 
Comparison of the Drug Effects on Secretion and 
ASGP-Receptor Recycling 
Studies of receptor-mediated endocytosis have shown that 
weak bases such as primaquine prevent the  dissociation of 
FIGURE  6  Effect  of  primaquine  on  intracellular  transport.  VSV- 
infected cells were labeled as described in the legend to Fig. I  and 
chased for 120 rain. At the indicated times primaquine was added 
to the  chase medium (I  ml). The cells were lysed in  0.5  ml  lysis 
buffer and 10 ~.I was used for gel analysis (top). I0-,I aliquots of the 
media were also applied on a gel (bottom; lanes I-7).  Lane 8, ceils 
and medium after a  10-min pulse and a 10-rain chase; lane 9, the 
same as lane 7, no primaquine added; lane I0, the same as lane 7, 
but uninfected cells were used. The VSV proteins and albumin are 
indicated to the right of the figure. 
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FIGURE  7  Effect  of  primaquine  (PMQ)  on  secretion  of  albumin 
(AIb), orosomucoid (Oro), and transferrin (Tf). These three proteins 
were quantitatively isolated  by immunoprecipitation from the cell 
lysates obtained from the experiment described in the legend  to 
Fig. 6. After gel electrophoresis and fluorography the bands were 
scanned.  The relative amounts of radioactivity are  plotted  in the 
figure. 
ligand-receptor complexes within  the  endosomal  compart- 
ment (CURL). This probably results from neutralization of 
the acid environment normally present in this compartment. 
In addition, in HepG2 cells in the absence of ligand prima- 
quine also prevents the recycling back to the surface of the 
internalized  ASGP  receptor.  However,  this  drug  does  not 
influence the rate at which the receptor enters the cell (25). 
This behavior has enabled us to compare the effect of pri- 
maquine on the intracellular transport of secretory proteins 
(and virus budding) with its effect on the return of recycling 
receptors to the the plasma membrane. VSV-infected HepG- 
2  cells were  incubated at  37"C  in  the  presence of various 
concentrations of primaquine for 2 h in order to reach equi- 
librium.  Thereafter the  cells  were  chilled  on  ice  and  the 
number of cell surface ASGP-receptor binding sites was de- 
termined using 125I-ASOR. Since the number of receptors at 
the cell surface is determined by the concentration of prima- 
quine, we can directly determine the dose-dependence of the 
return of receptor to the cell surface (Fig. 9B). Fig. 9A shows 
the dose-dependent effect of primaquine on protein secretion 
and virus budding.  Primaquine affects both ASGP-receptor 
recycling and  protein  secretion  in  exactly  the  same  way, 
supporting the  notion  that  both  processes  make  use  of a 
common mechanism. 
DISCUSSION 
The present results demonstrate that lysosomotropic agents 
such as NI-LCI and primaquine inhibit the intracellular trans- 
port  of secretory and  membrane proteins on  route  to  the 
plasma membrane in  a  post-Golgi compartment. We have 
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defined the site of primaquine action by three independent 
criteria: biochemically by the conversion of a "high mannose" 
to a "complex" sugar configuration of N-linked oligosaccha- 
rides as probed by sensitivity to endo H; kinetically by defining 
the actual intracellular transport rates; and morphologically 
by electron microscopic immunocytochemistry. The secretory 
transport route consists kinetically of at least two parts: from 
the RER to the Golgi complex and from the Golgi complex 
to the plasma membrane (2 l, 27). After synthesis in the RER 
(glyco)proteins are transported to the Golgi complex at differ- 
ent rates, presumably directed by interactions with compo- 
nents of the RER membranes. In some way these interactions 
induce differences in the transport rates for individual pro- 
teins, causing transport times to vary from 20 min for albumin 
to  2  h  for transferrin  (8,  14). The  second  portion  of the 
secretory pathway (Golgi complex-plasma membrane) may 
be either  "regulated" or  "constitutive" (30).  The regulated 
form of secretion occurs mainly in cells such as the pancreatic 
acinar  cells,  which  after  storage  in  granules  secrete  their 
proteins upon  stimulation  by calcium or cyclic AMP.  The 
"unregulated" or "constitutive" pathway occurs in fibroblasts 
and macrophages and is insensitive to regulation by cyclic 
AMP  or calcium.  Hepatocytes and  hepatoma cells  secrete 
serum proteins as albumin, tranferrin, and a, antitrypsin in a 
constitutive  manner.  Pulse-chase  experiments have shown 
that  the  transport  from the  Golgi  complex to  the  plasma 
membrane is bulk-phase and that the time needed to reach 
the plasma membrane is relatively short (<5  min at 37"C) 
(14, 24, 29). Primaquine primarily affects the second portion 
of the  transport  route.  Our  experiments demonstrate  that 
addition of the drug at the end of the pulse labeling causes 
considerable delay in the secretion of albumin, orosomucoid, 
and  transferrin.  Moreover, the  process of virus budding  is 
blocked almost instantaneously. Moore et al. demonstrated 
that chloroquine at a concentration of 0.2 mM diverts ACTH 
from a  regulated to a constitutive pathway in AtT-20 cells. 
Whether this  lysosomotropic agent also affects the  rate of 
ACTH secretion is not clear (16). 
The mechanism of action of the lysosomotropic agents has 
been the subject of intensive investigation (reviewed in refer- 
ence 7). This class of drugs inhibits lysosomal protein degra- 
dation at low concentrations (5, 34) and neutralizes the acidic 
environment in lysosomes and endosomes (15,  18,  19,  32). 
Many of these actions may be a direct consequence of pro- 
tonation within acidic intracellular compartments. Inhibition 
of transport  by primaquine  and  NI-LCI suggests  that  the 
secretory proteins pass through  such  a  compartment.  Fur- 
thermore, the kinetics of this inhibitory effect provides evi- 
dence for the intracellular localization of such a compartment. 
However, the inhibition of secretory transport is not identical 
for all proteins. Recently Oda et al. described the effect of 
NH4CI on protein secretion (l 7). Consistent with our results, 
NI-LCI only partly inhibited a~-antitrypsin and total secretion 
in rat hepatocytes. It is possible that some transport to the 
plasma  membrane  continues  to  occur  at  the  primaquine 
concentration used. This possibility is consistent with the slow 
and continued accumulation of labeled virus particles in the 
tissue culture medium in the presence of primaquine (Fig. l). 
It is not now clear why the inhibition is different for individual 
proteins. 
We have compared the  effect of primaquine  on  protein 
secretion  to  its  effect  on  ASGP  receptor  movement  and 
localization. As we reported previously primaquine induces a FIGURE 8  (A)  Ultrathin cryosections  of control cell, labeled for albumin with 6-nm gold particles. Albumin is predominantly 
located in the Golgi cisternae (C;). M, mitochondrion;  PM, plasma membrane. Bar, 0.2 #m. x  75,000. (B) Section of a cell incubated 
for 2 h with  10 mM NH4CI. Albumin is labeled with small (6 nm) and ASGP-receptor with large (9 nm) particles. Both albumin 
and the ASGP-receptor occur in vacuoles at the trans side of the Golgi system, sometimes clearly mixed together.  Bar, 0.2/~m. x 
62,500. 
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FIGURE  9  Comparison of the effect of primaquine on the secretion 
of proteins and binding of 1251-ASOR  to the HepG2 ASGP-receptor. 
Cells were pulse-labeled  for  10 rain and then chased for  120  min 
in the  presence  of various concentrations  of primaquine  as  indi- 
cated  in the figure. Albumin (O) and VSV-G  (@) were quantitated 
by  scanning of the  fluorographed  bands, and  the  results are  ex- 
pressed as the percentage  of the amount secreted  in the absence 
of the drug (A}. For the binding studies HepG2 cells were incubated 
at 37°C  for 120  rain in the presence  of various concentrations  of 
primaquine.  Thereafter  binding of 12SI-ASOR was performed  at 4°C 
in  the absence  and  presence  of excess unlabeled  ASOR  as  de- 
scribed  in Materials  and Methods.  The specific  binding  is plotted 
as a function of primaquine  concentration  (B). 
rapid loss of ASGP receptor from the cell surface of HepG2 
cells in a dose-dependent and reversible manner. This drug 
also prevents the return of the receptor to the cell  surface 
whether or not ligand is present.  However, primaquine has 
neither an effect on ligand binding to receptor nor on inter- 
nalization of the  receptor or  the  receptor-ligand  complex 
(25). Thus by determining the amount of ASGP binding sites 
at the cell surface as a function of primaquine concentration 
it is possible to determine the effect of the drug on receptor 
return to the plasma membrane. Our results show that the 
primaquine concentrations used to block receptor recycling 
are identical to those required to achieve inhibition of intra- 
cellular transport of (glyco) protein destined for secretion. The 
effective concentration of the drug is similar to that reported 
for  inhibition  of receptor-mediated  endocytosis  of ligands 
such as low density lipoprotein, ASOR, and a2-macroglobulin 
(2,  13,  25).  The striking similarity in inhibition  of the two 
processes  suggests  a  common  mechanism.  In  the  case  of 
receptor-mediated endocytosis acidification of the endosomal 
compartment appears to promote the  separation of ligand 
and receptor as exemplified by studies on the receptors for 
ASGPs and low density lipoproteins. Morphological studies 
in hepatocytes also demonstrate that a physical segregation of 
receptor and ligand occurs in the same acidic compartment 
(CURL) (9). This sorting process is prevented by lysomotropic 
agents.  Not  only  is  the  uncoupling  of the  receptor-ligand 
complex abrogated at neutral pH, but in addition the return 
of unoccupied receptors back to the cell surface is inhibited, 
resulting in intracellular accumulation of receptors. The pre- 
cise underlying mechanism of this effect of the lysosomotropic 
agents remains unknown. Nonetheless, the observation that 
the constitutive secretion of serum proteins in these cells is 
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inhibited in an identical manner suggests that bulk membrane 
transport to the cell surface is affected by primaquine. This 
idea is strengthened by the observation that virus budding is 
similarly inhibited by these agents, despite the fact that some 
of the  nonintegral  viral  proteins  are  present  and  allow  a 
modest degree of virus budding.  Our results are consistent 
with a recent study of Robbins et al. on the effect of a single 
mutation in Chinese hamster ovary cells with respect to Golgi 
complex  and  endosomal  function.  They  report  a  striking 
similarity between  the  alterations in  both  endocytotic and 
Golgi-associated steps of the maturation of viral proteins in a 
mutant cell  line  that  exhibits  a  decreased  ATP-dependent 
endosome acidification (20). 
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